If the FDA signs off on Moderna’s booster, the US Centres for Disease Control and Prevention will make specific recommendations on who should get the shots. Photo: AP
If the FDA signs off on Moderna’s booster, the US Centres for Disease Control and Prevention will make specific recommendations on who should get the shots. Photo: AP

US FDA panel backs Moderna coronavirus booster shot for older and high-risk people

  • The pharmaceutical firm is seeking authorisation for a half-strength third dose containing 50 micrograms of vaccine
  • The group of expert advisers to the Food and Drug Administration will weigh whether to make a similar recommendation for J&J’s vaccine on Friday

Topic |   Coronavirus pandemic
If the FDA signs off on Moderna’s booster, the US Centres for Disease Control and Prevention will make specific recommendations on who should get the shots. Photo: AP
If the FDA signs off on Moderna’s booster, the US Centres for Disease Control and Prevention will make specific recommendations on who should get the shots. Photo: AP
READ FULL ARTICLE